home1_b

TRIANNI and Antibody Discovery

Fully human monoclonal antibodies are powerful biological therapeutics.

Among many options available for isolating them, TRIANNI’s technology is distinguished by key advantages of ease of use, antibody diversity, and in vivo selection.

partnering
events

 

Biologics & Biosimilars Congress

PRESENTER
March 6–7, 2017  |  Berlin, Germany

PEGS Summit – Boston

PRESENTER
April 25–29, 2017  |  Boston, MA, USA

Save

Save

Save

Save

Save

Save